tailieunhanh - Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer

Adjuvant gemcitabine for pancreatic cancer has limited efficacy in the clinical setting. Impaired drug metabolism is associated with treatment resistance. We aimed to evaluate the chemosensitising effect of interferon-beta (IFN-β). |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN